1. PFE:NYQ

    Pfizer Inc

    USD

    36.06

    Today's change

    0.33 / +0.92%

    1 year change

    +25.64%

    As of Jul 31 2015 21:03 BST. Data delayed by at least 15 minutes.

Search for Pfizer Inc and
  1. July 30, 2015

    AstraZeneca beats earnings expectations despite strong dollar

    AstraZeneca is boosting research and development spending faster than expected, as it seeks to propel new drugs more...

  2. July 29, 2015

    Pharmaceuticals: Prescribing pain

    When Brandon had his appendix removed at the age of 26, his doctor gave him a supply of opioid-based painkillers to...

Special Reports

  1. Corporate Longevity

    The FT launches a global investigation into the mixture of innovation and focus that c...
  2. Innovation in Healthcare

    Health systems around the world face rising demand from an ageing population. More eff...
Search more Special Reports on this topic.

  1. July 29, 2015

    Wanted: recreational drug users with a nose for business

    Wanted: drug abuser who enjoys snorting opioids. Will pay $250 a day. Thousands of recreational drug users are being...

  2. July 28, 2015

    Pfizer chief executive has ‘sufficient courage’ to pursue deals

    Pfizer is scouting for acquisition targets and has “sufficient courage” to spend its cash on another company, its chief...

  3. July 27, 2015

    Allergan signals appetite for new mega deal after $41bn disposal

    It is just over a year since Brent Saunders became chief executive of Allergan, then known as Actavis, but he has...

  4. July 19, 2015

    Pfizer ranked top foreign research partner for UK academics

    Pfizer has more collaborations with British universities than any other foreign company according to a study that sheds...

  5. July 14, 2015

    Johnson & Johnson sales hit by ‘biosimilar’ competition

    International sales of Johnson & Johnson’s blockbuster anti-inflammatory drug fell more than 25 per cent in the second...

  6. June 25, 2015

    Johnson floats £10bn biotech fund for London

    Plans for a £10bn fund to boost investment in life sciences have been floated by Boris Johnson, London mayor, as part...

  7. June 21, 2015

    Saracen becomes more upbeat about US stocks

    Saracen’s Global Income and Growth fund has experienced a flurry of activity in the first half of 2015, as managers...

  8. June 21, 2015

    Pharmaceutical pollution in India is bitter pill for Nordea

    The largest investment house in the Nordic region has accused the world’s biggest pharmaceutical companies of ignoring...

  9. June 15, 2015

    US companies regain their appetite for tax inversion deals

    US companies have regained their appetite for controversial foreign takeovers that allow them to move overseas and...

  10. June 5, 2015

    Cancer treatment: Healing powers

    It felt more like a gathering of Silicon Valley entrepreneurs than a mainstream medical meeting. But the 30,000...

  11. June 2, 2015

    Financial pressure is a mind-altering drug for NHS and AstraZeneca

    The splendour of the National Health Service is illustrated by the redundancy of Breaking Bad’s plot arc in a British...

  12. May 31, 2015

    Clinical trials show cancer drug combo boosts survival rate

    A combination of two “immunotherapy” medicines made by Bristol-Myers Squibb can dramatically improve the chances of...

  13. May 29, 2015

    Novel cancer drugs tipped to boost drug sales

    In 1947, Sidney Farber, a pathologist working in a tiny hospital laboratory in Boston, gave an experimental cocktail of...

  14. May 28, 2015

    Biotech Cellectis in takeover talks with Pfizer

    Cellectis, the French biotech company, is in talks about its potential sale with Pfizer of the US believed to be among...

  15. May 28, 2015

    Fifa: Grand Theft Football

    Video game review Fifa 2015 Soccer (Foreign Corrupt Practices Edition) for Xbox and PS3, £22 from Esoteric Arts EA has...

  16. May 26, 2015

    Pfizer and AstraZeneca: one year after deal that never was

    It is a year this week since Pfizer admitted defeat in its £69.4bn hostile pursuit of AstraZeneca. The factors that led...

  17. May 20, 2015

    GSK unmoved by broker talk of takeover

    Broker theorising about a £90bn takeover was greeted with a shrug by GlaxoSmithKline shareholders. Deutsche Bank argued...

  18. May 17, 2015

    The Botox initiation of Brent Saunders, Actavis chief executive

    “I was a little ambushed,” says Brent Saunders, recalling how he ended up having his face injected with Botox and other...

  19. May 15, 2015

    The drugs to watch in fight against cancer

    About 30,000 doctors and scientists will arrive in Chicago in two weeks for the annual meeting of the American Society...

  20. May 10, 2015

    Top 50 US boardroom hoarders sit on $1tn in cash

    Just five US companies are hoarding nearly half a trillion dollars as the country’s tax code and a tepid global economy...

  21. April 30, 2015

    Weak euro lifts European drugmakers

    Sanofi and Bayer reported strong first-quarter results and raised guidance for the full year on Thursday, as drugmakers...

  22. April 28, 2015

    Investors sour on Coach turnround efforts

    Investors soured on Coach despite its turnround efforts after the retailer reported fiscal third-quarter results that...

  23. April 28, 2015

    Pfizer cuts forecasts as strong dollar bites

    Pfizer on Tuesday became the latest US drugmaker to warn a strengthening dollar was hurting its performance as it cut...

  24. April 26, 2015

    No end in sight to wave of pharma dealmaking

    Since the start of last year, pharmaceuticals companies have agreed $462bn of mergers and acquisitions — greater than...

  25. April 13, 2015

    Biotech: Making sense of the science

    It was supposed to be a wonder drug. Provenge promised to turn the body’s immune system into a weapon against disease,...

  26. April 9, 2015

    Robey Warshaw makes the big league with role in BG sale

    At the start of this week, a small London-based advisory firm run by two experienced dealmakers was nowhere to be found...

  27. April 7, 2015

    Big pharma turns to small biotechs for edge in cancer treatment

    Partnerships between big pharma and small biotech companies have highlighted the scramble for assets in a new category...

  28. April 3, 2015

    Pfizer halts China vaccine sales after import licence not renewed

    US drugmaker Pfizer has halted vaccine sales in China after an import licence for one of its top-selling treatments...

  29. FT Alphaville

    April 3, 2015

    FirstFT (the new 6am Cut)

    You can sign up to receive the email here. It’s a deal – after eight days of talks negotiators came to anagreement for...

  30. March 22, 2015

    Apple and Google stake a claim on big pharma’s turf

    Within 24 hours of Apple launching its platform for health research this month, tens of thousands of iPhone users had...

  31. March 19, 2015

    The charity that matches surplus medicine with acute need

    Pharmaceuticals executives might not seem the most likely recipients of hospitality from HRH the Prince of Wales. The...

  32. March 17, 2015

    Dementia research boosted by $100m venture capital fund

    Research into dementia is to be boosted by a $100m venture capital fund backed by the UK government and several of the...

  33. March 6, 2015

    Going the extra mile to win a $21bn deal

    The Pharmacyclics executives could hardly believe the turn of events. As they gathered on Wednesday at the drugmaker’s...

  34. February 25, 2015

    Pharmacyclics considers $19bn sale

    Pharmacyclics is considering a sale that could value the US cancer drugs maker at about $19bn, according to people...

  35. February 24, 2015

    Eli Lilly stays out of deals fray as it eyes ‘moon shot’ drugs

    The pharmaceutical industry is gripped by deals fever, but one company is conspicuously absent from the lists of...

  36. February 22, 2015

    Valeant agrees to buy Salix for $14.5bn

    Valeant, the serial pharmaceuticals dealmaker, has agreed to buy Salix in an all-cash transaction that values the...

  37. February 19, 2015

    Sanofi appoints Brandicourt as CEO

    Sanofi has named Olivier Brandicourt of Bayer as its new chief executive, ending a four-month search to replace Chris...

  38. February 11, 2015

    M&A helps lift US healthcare stocks

    Gilead Sciences, the biotech behemoth that has seen its market valuation soar to a cool $145bn, has put in a strong...

Search for Pfizer Inc and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Lex on the rejection of Pfizer's ‘final’ bid...
    May 19, 2014

    Lex on the rejection of Pfizer's ‘final’ bid

  2. The FT debates Pfizer's takeover bid for AstraZeneca...
    May 13, 2014

    The FT debates Pfizer's takeover bid for AstraZeneca